The changing landscape in the treatment of metastatic castration-resistant prostate cancer
The past few years have brought increasing advances in the therapeutic management of metastatic castration-resistant prostate cancer with the approval of several agents, including vaccine therapy with sipuleucel-T, second-line chemotherapy with cabazitaxel, the bone-targeted pharmaceutical denosumab...
Saved in:
| Main Author: | |
|---|---|
| Other Authors: | |
| Format: | article |
| Published: |
2012
|
| Online Access: | http://hdl.handle.net/10725/6239 http://dx.doi.org/ 10.1177/ 1758834012458137 http://libraries.lau.edu.lb/research/laur/terms-of-use/articles.php http://journals.sagepub.com/doi/abs/10.1177/1758834012458137 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|